Aurora Pharmacy Inc | |
1575 N Rivercenter Dr, Milwaukee, Wisconsin 53212 | |
(414) 224-1555 |
Name | Aurora Pharmacy Inc |
---|---|
Organization Name | Aurora Pharmacy Inc |
Location | 1575 N Rivercenter Dr, Milwaukee, Wisconsin 53212 |
Type | Clinic Pharmacy |
Phone | (414) 224-1555 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.
In structural biology, the only technique available to predict the three dimensional structure of large complex molecules in solution, such as proteins and DNA, is NMR spectroscopy. To catalyze improvements in the techniques behind these predictions, the "eNMR" project has launched a new initiative. In September's Nature Methods the project issued an invitation to the entire biomolecular Nuclear Magnetic Resonance community to participate in a large scale test of modern computing algorithms.
A new study has raised serious concerns about how some people prescribed antidepressants are affected by the drugs.
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
› Verified 6 days ago
NPI Number | 1487029351 |
Organization Name | AURORA PHARMACY |
Type | Clinic Pharmacy |
Address | 1575 N Rivercenter Dr, Milwaukee, WI 53212 |
Phone Number | 414-224-1555 |
News Archive
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.
In structural biology, the only technique available to predict the three dimensional structure of large complex molecules in solution, such as proteins and DNA, is NMR spectroscopy. To catalyze improvements in the techniques behind these predictions, the "eNMR" project has launched a new initiative. In September's Nature Methods the project issued an invitation to the entire biomolecular Nuclear Magnetic Resonance community to participate in a large scale test of modern computing algorithms.
A new study has raised serious concerns about how some people prescribed antidepressants are affected by the drugs.
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
› Verified 6 days ago
NPI Number | 1639103856 |
Organization Name | AURORA PHARMACY INC |
Doing Business As | AURORA PHARMACY 110 MILWAUKEE |
Type | Pharmacy |
Address | 1575 N Rivercenter Dr, Milwaukee, WI 53212 |
Phone Number | 414-224-1555 |
News Archive
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.
In structural biology, the only technique available to predict the three dimensional structure of large complex molecules in solution, such as proteins and DNA, is NMR spectroscopy. To catalyze improvements in the techniques behind these predictions, the "eNMR" project has launched a new initiative. In September's Nature Methods the project issued an invitation to the entire biomolecular Nuclear Magnetic Resonance community to participate in a large scale test of modern computing algorithms.
A new study has raised serious concerns about how some people prescribed antidepressants are affected by the drugs.
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
› Verified 6 days ago
News Archive
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.
In structural biology, the only technique available to predict the three dimensional structure of large complex molecules in solution, such as proteins and DNA, is NMR spectroscopy. To catalyze improvements in the techniques behind these predictions, the "eNMR" project has launched a new initiative. In September's Nature Methods the project issued an invitation to the entire biomolecular Nuclear Magnetic Resonance community to participate in a large scale test of modern computing algorithms.
A new study has raised serious concerns about how some people prescribed antidepressants are affected by the drugs.
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
› Verified 6 days ago
Novacare Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 10700 W Burleigh St, Milwaukee, Wisconsin 53222 Phone: (414) 778-4500 | |
Aurora Health Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3003 W Good Hope Rd, Milwaukee, Wisconsin 53209 Phone: (414) 352-3100 | |
Asimc Pharmacy Type: Institutional Pharmacy Location: 2900 W. Oklahoma Ave, Milwaukee, Wisconsin 53215 Phone: (414) 649-6930 | |
Aslmc Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2801 W Kinnickinnic River Pkwy, Milwaukee, Wisconsin 53215 Phone: (414) 649-6738 | |
Asmc Pharmacy Type: Institutional Pharmacy Location: 945 No 12th St, Milwaukee, Wisconsin 53233 Phone: (414) 219-3100 |